Marathon Asset Management Ltd Grows Stock Holdings in Teleflex Incorporated $TFX

Marathon Asset Management Ltd increased its position in shares of Teleflex Incorporated (NYSE:TFXFree Report) by 58.8% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 102,894 shares of the medical technology company’s stock after buying an additional 38,107 shares during the period. Marathon Asset Management Ltd’s holdings in Teleflex were worth $12,557,000 as of its most recent filing with the SEC.

A number of other hedge funds have also recently added to or reduced their stakes in the company. Banque Cantonale Vaudoise boosted its holdings in Teleflex by 82.5% during the fourth quarter. Banque Cantonale Vaudoise now owns 250 shares of the medical technology company’s stock worth $31,000 after buying an additional 113 shares in the last quarter. Mission Wealth Management LP purchased a new stake in Teleflex during the fourth quarter worth $203,000. Tejara Capital Ltd boosted its holdings in Teleflex by 871.3% during the fourth quarter. Tejara Capital Ltd now owns 77,700 shares of the medical technology company’s stock worth $9,483,000 after buying an additional 69,700 shares in the last quarter. Thrivent Financial for Lutherans boosted its holdings in Teleflex by 40.6% during the fourth quarter. Thrivent Financial for Lutherans now owns 774,034 shares of the medical technology company’s stock worth $94,463,000 after buying an additional 223,585 shares in the last quarter. Finally, Baader Bank Aktiengesellschaft boosted its holdings in Teleflex by 32.4% during the fourth quarter. Baader Bank Aktiengesellschaft now owns 43,333 shares of the medical technology company’s stock worth $5,288,000 after buying an additional 10,600 shares in the last quarter. 95.62% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of analysts recently issued reports on the stock. Zacks Research raised shares of Teleflex from a “strong sell” rating to a “hold” rating in a report on Tuesday, April 28th. Weiss Ratings restated a “sell (d)” rating on shares of Teleflex in a research report on Friday, March 27th. Bank of America upgraded shares of Teleflex from an “underperform” rating to a “neutral” rating and set a $135.00 price objective for the company in a research report on Monday, April 13th. Royal Bank Of Canada upgraded shares of Teleflex from a “sector perform” rating to an “outperform” rating and upped their price objective for the stock from $135.00 to $155.00 in a research report on Friday, May 8th. Finally, Mizuho set a $140.00 price objective on shares of Teleflex in a research report on Friday, May 8th. Three analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $144.00.

Check Out Our Latest Analysis on Teleflex

Teleflex Stock Performance

NYSE:TFX opened at $133.01 on Wednesday. The company has a debt-to-equity ratio of 0.82, a quick ratio of 2.03 and a current ratio of 2.55. The company has a fifty day moving average of $121.39 and a two-hundred day moving average of $116.69. The stock has a market capitalization of $5.89 billion, a PE ratio of -5.83, a P/E/G ratio of 0.97 and a beta of 0.82. Teleflex Incorporated has a fifty-two week low of $100.18 and a fifty-two week high of $139.67.

Teleflex (NYSE:TFXGet Free Report) last posted its quarterly earnings data on Thursday, May 7th. The medical technology company reported $1.39 earnings per share for the quarter, topping analysts’ consensus estimates of $1.21 by $0.18. The company had revenue of $548.30 million during the quarter, compared to analysts’ expectations of $536.91 million. Teleflex had a negative net margin of 35.88% and a positive return on equity of 13.29%. The firm’s revenue for the quarter was up 32.3% on a year-over-year basis. During the same period in the prior year, the business posted $1.44 earnings per share. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. As a group, research analysts forecast that Teleflex Incorporated will post 6.7 earnings per share for the current fiscal year.

Teleflex Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 30th. Stockholders of record on Monday, May 25th will be given a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.0%. The ex-dividend date is Friday, May 22nd. Teleflex’s dividend payout ratio is -5.96%.

Teleflex Profile

(Free Report)

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.

See Also

Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFXFree Report).

Institutional Ownership by Quarter for Teleflex (NYSE:TFX)

Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.